The Impact of Psychological Intervention on the Emotions and Prognosis of Children with Chronic Kidney Disease

DOI: https://doi.org/10.62517/jmhs.202605110

Author(s)

Yan Dai

Affiliation(s)

Department of Stomatology, Jiangxi Provincial Children's Hospital, Nanchang, Jiangxi, China

Abstract

Study effects of psychological interventions on emotions & outcomes for kids with chronic kidney disease. In our hospital from January 2021 to December 2023, we recruited a cohort of 75 children with a diagnosis of CKD who were admitted to the hospital. Then these were randomly put into two groups with a random number table, the observation group(n=38) and the control group(n=37). Control group got ordinary health education plus regular therapy, observation group got organized psychological interventions along with regular therapy. Compared the scores of the two groups on SAS and SDS scales, the two groups' medicine compliance, therapeutic effect, change of clinical physiological index before and after treatment, the incidence of complications and adverse reaction. After the end of the 24-week intervention period, the observation group's SAS and SDS scores were (49.26 ± 8.93) and (49.61±9.06), which were obviously less than those of the control group which were (58.59 ± 8.63) and (58.95 ± 8.78). And also in terms of medication adherence, the observation group has much better adherence than the control group and there is also a difference between the two and this difference is also statistically significant (P<0.05). The total effective rate of the observation group was 97.37%, which was higher than the 78.38% of the control group, P<0.05. Also, it can be seen from the post-treatment that the 24 hours Urine Protein, Blood urea nitrogen, and Systolic blood pressure were notably decreased in the observation group when compared to the control group (P < 0.05). The incidence of complications and adverse reactions was lower in the observation group (15.79%) than in the control group (48.65%), P<0.05. Psychological interventions have the potential to mitigate negative emotions, enhance adherence to treatment protocols, decrease the occurrence of complications and adverse reactions, and then help sick children with kidney problems get better faster.

Keywords

Chronic Kidney Disease; Child; Psychological Intervention; Medication Compliance

References

[1] Cheng J L, Du Y. Overview of chronic kidney disease in children. International Journal of Pediatrics, 2016, 43(10): 788-792. [2] Expert Group of Shanghai Clinical Quality Control Center for Nephrology. Guidelines for early screening, diagnosis, prevention and treatment of chronic kidney disease (2022 Edition). Chinese Journal of Nephrology, 2022, 38(5): 453-464. [3] Ehsan A, Aziz M, Lanewala A A, et al. Prevalence of cardiac abnormalities in children with chronic kidney disease: A cross-sectional study from a developing country. Saudi Journal of Kidney Diseases and Transplantation: An Official Publication of the Saudi Center for Organ Transplantation, Saudi Arabia, 2021, 32(1): 92-100. [4] Chou H H, Lin C Y, Chiou Y H, et al. Clinical characteristics and prevalence of complications of chronic kidney disease in children: The taiwan pediatric renal collaborative study. Pediatric Nephrology (berlin, Germany), 2016, 31(7): 1113-1120. [5] Kim J J, Booth C J, Waller S, et al. The demographic characteristics of children with chronic kidney disease stages 3-5 in south east England over a 5-year period. Archives of Disease in Childhood, 2013, 98(3): 189-194. [6] Fu L L, Jian D Y, Zhang L H. Project-Based Operation Research on Pediatric Medical Game Counseling — Practice Exploration of Medical Social Workers at the Pediatric Hospital Affiliated to Fudan University. China Social Work, 2019(36): 39-43. [7] Kogon A J, Matheson M B, Flynn J T, et al. Depressive symptoms in children with chronic kidney disease. Journal of Pediatrics, 2016, 168: 164-170.e1. [8] Dryjańska N, Kiliś-Pstrusińska K. Depression in children and adolescents with chronic kidney disease-review of available literature. Journal of Clinical Medicine, 2023, 12(10): 3554. [9] Herman J P, McKlveen J M, Ghosal S, et al. Regulation of the hypothalamic-pituitary-adrenocortical stress response. Comprehensive Physiology, 2016, 6(2): 603-621. [10] Sagmeister M S, Harper L, Hardy R S. Cortisol excess in chronic kidney disease - a review of changes and impact on mortality. Frontiers in Endocrinology, 2022, 13: 1075809. [11] Akchurin O M, Schneider M F, Mulqueen L, et al. Medication adherence and growth in children with CKD. Clinical Journal of The American Society of Nephrology: Cjasn, 2014, 9(9): 1519-1525. [12] Ganguly A, Hulke S M, Bharshanakar R, et al. Effect of meditation on autonomic function in healthy individuals: A longitudinal study. Journal of Family Medicine and Primary Care, 2020, 9(8): 3944-3948. [13] Clinical practice guidelines for nutrition in chronic renal failure. K/DOQI, national kidney foundation. American Journal of Kidney Diseases: The Official Journal of The National Kidney Foundation, 2000, 35(6 Suppl 2): S17-S104. [14] Kamath N, Iyengar A, George N, et al. Risk factors and rate of progression of CKD in children. Kidney International Reports, 2019, 4(10): 1472-1477. [15] Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International, 2024, 105(4S): S117-S314.